by Dr. Corey Cutler, MD, MPH
In April's president's message, Dr. Corey Cutler, MD, MPH, reflects on the recent successful Tandem meeting in San Antonio and acknowledges the challenges of daily work.
by Alex Kadhim
Researchers from Memorial Sloan Kettering Cancer Center in New York have explored the potential of personalized fludarabine dosing, based on population pharmacokinetics (PK), to enhance the...
by Alex Kadhim
Researchers at the University of Birmingham in the UK have explored the dynamics of inflammatory biomarkers following allogeneic hematopoietic stem cell transplantation.
by BMJ Journals
Preclinical evidence identifies human epidermal growth factor receptor 2 (HER2) as a promising candidate for chimeric antigen receptor (CAR) T-cell therapy in solid cancers but it is best to...
by Alex Kadhim
Researchers have discovered a significant function of the Id3 protein in the persistence and operational capabilities of tissue-infiltrating alloreactive T cells, offering insights that could...
by Nature Medicine
Off-the-shelf chimeric antigen receptor natural killer (CAR-NK) cells are a more affordable and safer alternative to autologous anti-CD19 CAR T cells for the treatment of CD19+ B cell malignancies.